Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of a protein kinase inhibitor and an additional chemotherapeutic agent

Combination of a protein kinase inhibitor and an additional chemotherapeutic agent

US Patent 11246929 · Granted Feb 15, 2022

Estimated economic value: $307,500,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination of a PD-1 antagonist, an ATR inhibitor and a platinating agent for t2025
Substituted imidazoquinolines2018
7-azaindole derivatives2017
Substituted imidazoquinolines2016
Fused bicyclic imidazoles2016
7-azaindole derivatives2016
Substituted imidazoquinolines2015
7-azaindole derivatives2015
Quinazoline derivatives2014
N-sulphonylpyrroles and their use as histone deacetylase inhibitors2014
Triazole derivative as an HSP 90 inhibitor2014
Phenylquinazoline derivatives2014